Correlation Between Neuropace and Cerus
Can any of the company-specific risk be diversified away by investing in both Neuropace and Cerus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Cerus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Cerus, you can compare the effects of market volatilities on Neuropace and Cerus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Cerus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Cerus.
Diversification Opportunities for Neuropace and Cerus
Very weak diversification
The 3 months correlation between Neuropace and Cerus is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Cerus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerus and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Cerus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerus has no effect on the direction of Neuropace i.e., Neuropace and Cerus go up and down completely randomly.
Pair Corralation between Neuropace and Cerus
Given the investment horizon of 90 days Neuropace is expected to generate 1.19 times more return on investment than Cerus. However, Neuropace is 1.19 times more volatile than Cerus. It trades about -0.06 of its potential returns per unit of risk. Cerus is currently generating about -0.17 per unit of risk. If you would invest 1,376 in Neuropace on December 2, 2024 and sell it today you would lose (81.00) from holding Neuropace or give up 5.89% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. Cerus
Performance |
Timeline |
Neuropace |
Cerus |
Neuropace and Cerus Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Cerus
The main advantage of trading using opposite Neuropace and Cerus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Cerus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerus will offset losses from the drop in Cerus' long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
CEOs Directory Screen CEOs from public companies around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |